Featuring perspectives from Drs John Heymach and Zofia Piotrowska, including the following topics: 

• Introduction (0:00)
• Common questions related to targeted therapy for non-small cell lung cancer (NSCLC) (2:32)
• Key data sets guiding the management of NSCLC with common EGFR mutations (16:30)
• Management of NSCLC with EGFR exon 20 insertion mutations (28:18)
• NSCLC with ALK and ROS1 alterations (34:11)
• Caring for patients with HER2-mutant NSCLC (37:14)
• Targeting TROP2 in NSCLC (45:20)
• NSCLC with MET exon 14 skipping mutations; RET fusion-positive NSCLC (47:19)
• Targeting KRAS mutations in NSCLC (55:44)

CME information and select publications